EMBOLIZATION | ||||||
---|---|---|---|---|---|---|
Number of patients | % | |||||
Successful embolization (number of CSFVF) | 30 (48) | 100% | ||||
Overall Complications | 10 | 33% | ||||
Permanent complications | 0 | 0% | ||||
Transient complications | 10 | 33% | ||||
Type of complication | ||||||
- Transient local pain - Perforation of the epidural plexus - Onyx migration into the Azygos vein | 7 1 2 | 23% 3% 6% | ||||
Overall rate of recurrent symptoms | 3 | 10% | ||||
Overall rate of patients requiring repeated CSFVF embolization | 3 | 10% | ||||
Patients developing post-treatment rebound headache | 12 | 40% | ||||
Patients receiving medical treatment for rebound headache | 6 | 20% | ||||
CLINICAL SYMPTOM EVOLUTION AFTER EMBOLIZATION | ||||||
Number of patients | Recovery after CSFVF embolization | |||||
Complete | Partial | No recovery | ||||
Global | ||||||
Self-evaluated improvement after treatment | 30 (100%) | 19 (63%) | 11 (37%) | 0 | ||
Headaches | ||||||
Headache | 28 (93%) | 18 (64%) | 10 (35%) | 0 (0%) | ||
Orthostatic | 19 (68%) | 15 (79%) | 4 (21%) | 0 (0%) | ||
Non-Orthostatic | 3 (10%) | 2 (67%) | 0 (0%) | 1 (33%) | ||
Exertion | 22 (78%) | 19 (86%) | 3 (13,6%) | 0 (0%) | ||
Cough | 20 (71%) | 18 (90%) | 2 (10%) | 0 (0%) | ||
Audio-vestibular | ||||||
Dizziness/Vertigo | 19 (63%) | 8 (42%) | 7 (37%) | 5 (26%) * | ||
Tinnitus | 13 (43%) | 5 (38%) | 3 (23%) | 7 (54%) ** | ||
Hearing disturbance | 12 (40%) | 3(25%) | 4 (33%) | 5 (42%) | ||
Psychological | ||||||
Depression | 15 (50%) | 9 (60%) | 5 (33%) | 1 (7%) | ||
Anxiety | 19 (63%) | 8 (42%) | 6 (32%) | 5 (26%) | ||
Suicide ideation | 3 (10%) | 3 (100%) | 0 (0%) | 0 (0%) |